I love the products. I will definitely order some more from this store.
hello
I'm so glad you like the product.
You can apply it to the wound
Thank you for your review.
1
/
of
1
한국코러스(주)
Keitoba tablet (Heart disease)
Keitoba tablet (Heart disease)
No reviews
Regular price
$47.00 USD
Regular price
Sale price
$47.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
1) Efficacy, effect
1. Reduced risk of the following cardiovascular diseases:
1) Adult patients with no clinical evidence of coronary heart disease but with multiple risk factors for coronary heart disease
Patients with type 2 diabetes who have multiple risk factors for coronary heart disease but do not have clinical evidence of coronary heart disease
Adult patients with clinical evidence of coronary heart disease
2. Hyperlipidemia
3. Total cholesterol, LDL-cholesterol, and apo-B protein in pediatric patients aged 10 to 17 years (for women, patients after menarche) with heterozygous familial hypercholesterolemia who still meet the criteria below despite dieting. Dietary supplements to reduce levels
2) Usage, dosage
Patients before and while taking atorvastatin must eat a standard cholesterol-lowering diet, and the drug can be administered at any time of the day, regardless of food.
1. Hyperlipidemia
The recommended initial dose is 10 mg of atorvastatin once a day, but for patients who require a greater reduction in LDL-cholesterol levels, 20 mg or 40 mg once a day (if a reduction in LDL-cholesterol levels of 45% or more is required) (limited to) can start with . This drug is administered once a day in a dosage range of 10 to 80 mg.
The initial dose and maintenance dose of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and responses. After starting administration and/or dose titration, lipid levels are analyzed within 2 to 4 weeks, and the dose is adjusted accordingly. Need to adjust.
Since the goal of treatment is to lower LDL-cholesterol levels, it is recommended to use LDL-cholesterol levels when starting treatment and evaluating treatment response. However, when LDL-cholesterol levels are not available, total cholesterol levels are used to monitor treatment response.
Patients with homozygous familial hypercholesterolemia
The dosage of this drug is 10 to 80 mg once a day, and it is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such lipid-lowering treatments are not possible.
2. Pediatric patients (10 to 17 years old) with heterozygous familial cholesterolemia
The recommended initial dose of this drug is 10 mg per day, and the maximum recommended dose is 20 mg per day (there is no clinical data on administering doses higher than 20 mg of this drug in pediatric patients.) The administered dose is appropriately increased or decreased depending on the treatment goal recommended for each patient. The dosage should be adjusted at intervals of 4 weeks or more.
- Patients with renal impairment:
Kidney disease does not affect the plasma concentration or LDL-cholesterol lowering effect of atorvastatin, so there is no need to adjust the dose.
- Elderly:
Efficacy and safety in elderly patients over 70 years of age are similar to those in adult patients.
6) Storage method
1. Hyperlipidemia
The recommended initial dose is 10 mg of atorvastatin once a day, but for patients who require a greater reduction in LDL-cholesterol levels, 20 mg or 40 mg once a day (if a reduction in LDL-cholesterol levels of 45% or more is required) (limited to) can start with . This drug is administered once a day in a dosage range of 10 to 80 mg.
The initial dose and maintenance dose of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and responses. After starting administration and/or dose titration, lipid levels are analyzed within 2 to 4 weeks, and the dose is adjusted accordingly. Need to adjust.
Since the goal of treatment is to lower LDL-cholesterol levels, it is recommended to use LDL-cholesterol levels when starting treatment and evaluating treatment response. However, when LDL-cholesterol levels are not available, total cholesterol levels are used to monitor treatment response.
Patients with homozygous familial hypercholesterolemia
The dosage of this drug is 10 to 80 mg once a day, and it is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such lipid-lowering treatments are not possible.
2. Pediatric patients (10 to 17 years old) with heterozygous familial cholesterolemia
The recommended initial dose of this drug is 10 mg per day, and the maximum recommended dose is 20 mg per day (there is no clinical data on administering doses higher than 20 mg of this drug in pediatric patients.) The administered dose is appropriately increased or decreased depending on the treatment goal recommended for each patient. The dosage should be adjusted at intervals of 4 weeks or more.
- Patients with renal impairment:
Kidney disease does not affect the plasma concentration or LDL-cholesterol lowering effect of atorvastatin, so there is no need to adjust the dose.
- Elderly:
Efficacy and safety in elderly patients over 70 years of age are similar to those in adult patients.
3) Packaging unit
30 tablets/bottle
4) Ingredients, content
Atorvastatin Calcium Hydrate Atorvastatin Calcium Hydrate 10.85mg (10mg as Atorvastatin)
5) Period of use
36 months from date of manufacture
6) Storage method
Airtight container, stored at room temperature (1~30°C)
Share
